Related Experiment Video
Updated: Jun 11, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2
David Yao1, Raj S Patel1, Adrien Lam1
1Department of Surgery, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Abstract:
There is a need to investigate novel strategies in order to create an effective, broadly protective vaccine for current and future severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks. The currently available vaccines demonstrate compromised efficacy against emerging SARS-CoV-2 variants of concern (VOCs), short-lived immunity, and susceptibility to immune imprinting due to frequent boosting practices. In this study, we examined the specificity of cross-reactive IgG antibody responses in mRNA-vaccinated, AstraZeneca-vaccinated, and unvaccinated donors to identify potentially conserved, cross-reactive epitopes to target in order to create a broadly protective SARS-CoV-2 vaccine. Our study provides evidence for cross-reactive IgG antibodies specific to eight different spike (S) variants. Furthermore, the specificities of these cross-variant IgG antibody titers were associated to some extent with spike S1- and S2-subunit-derived epitopes P1 and P2, respectively. In addition, nucleocapsid (N)- and membrane (M)-specific IgG antibody titers correlated with N- and M-derived epitopes conserved across beta-CoVs, P3-7. This study reveals conserved epitopes of viral antigens, targeted by natural and/or vaccine-induced human immunity, for future designs of next-generation COVID-19 vaccines.
Insights
Researchers identified conserved viral epitopes that could be targeted for next-generation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. This strategy aims to improve broad protection against current and future coronavirus outbreaks.
Area of Science:
- Immunology
- Virology
- Vaccine Development
Background:
- Current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show reduced efficacy against variants of concern and offer short-lived immunity.
- Frequent vaccine boosting may lead to immune imprinting, further complicating vaccine effectiveness.
Purpose of the Study:
- To investigate conserved cross-reactive epitopes for developing broadly protective SARS-CoV-2 vaccines.
- To analyze IgG antibody responses in vaccinated and unvaccinated individuals against SARS-CoV-2 variants.
Main Methods:
- Examined IgG antibody responses in mRNA-vaccinated, AstraZeneca-vaccinated, and unvaccinated donors.
- Assessed antibody specificity against eight different spike (S) variants.
- Correlated antibody titers with specific epitopes on S, nucleocapsid (N), and membrane (M) proteins.
Main Results:
- Identified cross-reactive IgG antibodies targeting eight SARS-CoV-2 spike variants.
- Observed associations between antibody titers and spike S1/S2 subunit epitopes (P1, P2).
- Found correlations between N/M-specific IgG titers and conserved beta-coronavirus epitopes (P3-7).
Conclusions:
- Revealed conserved viral epitopes targeted by natural and vaccine-induced immunity.
- Provides a foundation for designing next-generation COVID-19 vaccines with broader protective capabilities.
- Highlights potential targets for improved SARS-CoV-2 vaccine strategies against emerging variants.
More Related Videos
Related Concept Videos
Cross-reactivity
Vaccinations
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Humoral Immune Responses
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

